C3.ai (NYSE:AI) Issues Earnings Results, Misses Estimates By $0.37 EPS

C3.ai (NYSE:AIGet Free Report) posted its quarterly earnings results on Wednesday. The company reported ($0.62) earnings per share for the quarter, missing the consensus estimate of ($0.25) by ($0.37), Zacks reports. C3.ai had a negative return on equity of 31.31% and a negative net margin of 79.17%. C3.ai updated its Q4 2025 guidance to EPS and its FY 2025 guidance to EPS.

C3.ai Trading Up 0.4 %

Shares of NYSE AI traded up $0.10 during mid-day trading on Wednesday, reaching $26.43. The company had a trading volume of 7,967,059 shares, compared to its average volume of 4,880,479. C3.ai has a 52 week low of $18.85 and a 52 week high of $45.08. The business’s 50-day moving average is $33.15 and its 200-day moving average is $29.61. The stock has a market cap of $3.41 billion, a price-to-earnings ratio of -11.96 and a beta of 1.98.

Insider Activity at C3.ai

In related news, VP Merel Witteveen sold 11,132 shares of the company’s stock in a transaction dated Monday, December 30th. The shares were sold at an average price of $34.95, for a total value of $389,063.40. Following the completion of the sale, the vice president now directly owns 4,142 shares of the company’s stock, valued at $144,762.90. This represents a 72.88 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Hitesh Lath sold 3,949 shares of the firm’s stock in a transaction dated Tuesday, December 17th. The shares were sold at an average price of $42.36, for a total transaction of $167,279.64. Following the transaction, the chief financial officer now directly owns 851 shares in the company, valued at $36,048.36. This trade represents a 82.27 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 1,643,311 shares of company stock worth $59,736,620 in the last 90 days. 33.54% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of research firms have issued reports on AI. StockNews.com raised C3.ai to a “sell” rating in a research note on Tuesday, November 26th. Canaccord Genuity Group upped their price target on shares of C3.ai from $23.00 to $40.00 and gave the company a “hold” rating in a research note on Wednesday, December 11th. DA Davidson upgraded shares of C3.ai to a “hold” rating in a research report on Wednesday, December 18th. Northland Securities boosted their target price on shares of C3.ai from $35.00 to $45.00 and gave the stock an “outperform” rating in a report on Tuesday, December 10th. Finally, JPMorgan Chase & Co. cut shares of C3.ai from a “neutral” rating to an “underweight” rating and set a $28.00 target price on the stock. in a research report on Wednesday, December 11th. Five investment analysts have rated the stock with a sell rating, five have issued a hold rating, four have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $35.00.

Read Our Latest Analysis on AI

C3.ai Company Profile

(Get Free Report)

C3.ai, Inc operates as an enterprise artificial intelligence (AI) software company in North America, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides C3 AI platform, an application development and runtime environment that enables customers to design, develop, and deploy enterprise AI applications; C3 AI Ex Machina for analysis-ready data; C3 AI CRM, an industry specific customer relationship management solution; and C3 Generative AI Product Suite that enables to locate, retrieve, and present information.

Featured Articles

Earnings History for C3.ai (NYSE:AI)

Receive News & Ratings for C3.ai Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for C3.ai and related companies with MarketBeat.com's FREE daily email newsletter.